Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleonora De Luca

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Dermatology Practical & Conceptual|August 12, 2025
Patient Satisfaction with Calcipotriol/Betamethasone Dipropionate Cream in Psoriatic Patients Previously Treated With Foam VehicleGiacomo Caldarola, Enrico Bocchino, Eleonora De Luca, et al.
Dermatology Research and Practice|January 22, 2024
Facial Papulopustular Eruption during the COVID-19 Pandemic in Patients Treated with EGFR InhibitorsEleonora De Luca, Pietro Sollena, Lucia Di Nardo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 30, 2025
Stigmatizing attitudes towards facial psoriasis, atopic dermatitis, vitiligo and alopecia areataEleonora De Luca, Giacomo Caldarola, Michele Casciola, et al.
International Journal of Dermatology|October 7, 2024
Residual disease is the main, but not the only factor impacting satisfaction in psoriatic patients undergoing biological therapiesGiacomo Caldarola, Eleonora De Luca, Gennaro Marco Falco, et al.
International Journal of Dermatology|May 22, 2026
The Psoriasis-Eczema Interface: Clinical Classification and Therapeutic Implications From a Bicentric ExperienceMichela D'Agostino, Gennaro Marco Falco, Eleonora De Luca, et al.
International Journal of Dermatology|February 25, 2024
Clinical, epidemiological, and therapeutic hallmarks of pyoderma gangrenosum: a case series of 35 patientsGiacomo Caldarola, Daniele O Traini, Gennaro M Falco, et al.
International Journal of Dermatology|September 1, 2025
No Increased Risk of Thromboembolic Events During 6-Month Treatment With Baricitinib in Patients With Alopecia AreataGiacomo Caldarola, Antonietta Ferretti, Lorenzo Maria Pinto, et al.
Dermatology Practical & Conceptual|May 29, 2024
Long-Term Effectiveness of Brodalumab for the Treatment of Moderate-To-Severe Psoriasis: A Real-Life Multicenter Study of Up to 3 Years in a Real-Life Italian CohortGiacomo Caldarola, Marco Galluzzo, Nicoletta Bernardini, et al.
Dermatology (Basel, Switzerland)|June 18, 2024
Evaluation of the Impact of Night Shift Work on Disease Severity in Psoriatic Patients: A Case-Control Study with Clinical, Hormonal, and Immunological EvaluationGiacomo Caldarola, Eleonora De Luca, Angelina Barini, et al.
Frontiers in Medicine|January 26, 2024
Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilledGiulia Coscarella, Gennaro Marco Falco, Gerardo Palmisano, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Dermatology Practical & Conceptual|August 12, 2025
Patient Satisfaction with Calcipotriol/Betamethasone Dipropionate Cream in Psoriatic Patients Previously Treated With Foam VehicleGiacomo Caldarola, Enrico Bocchino, Eleonora De Luca, et al.
Dermatology Research and Practice|January 22, 2024
Facial Papulopustular Eruption during the COVID-19 Pandemic in Patients Treated with EGFR InhibitorsEleonora De Luca, Pietro Sollena, Lucia Di Nardo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 30, 2025
Stigmatizing attitudes towards facial psoriasis, atopic dermatitis, vitiligo and alopecia areataEleonora De Luca, Giacomo Caldarola, Michele Casciola, et al.
International Journal of Dermatology|October 7, 2024
Residual disease is the main, but not the only factor impacting satisfaction in psoriatic patients undergoing biological therapiesGiacomo Caldarola, Eleonora De Luca, Gennaro Marco Falco, et al.
International Journal of Dermatology|May 22, 2026
The Psoriasis-Eczema Interface: Clinical Classification and Therapeutic Implications From a Bicentric ExperienceMichela D'Agostino, Gennaro Marco Falco, Eleonora De Luca, et al.
International Journal of Dermatology|February 25, 2024
Clinical, epidemiological, and therapeutic hallmarks of pyoderma gangrenosum: a case series of 35 patientsGiacomo Caldarola, Daniele O Traini, Gennaro M Falco, et al.
International Journal of Dermatology|September 1, 2025
No Increased Risk of Thromboembolic Events During 6-Month Treatment With Baricitinib in Patients With Alopecia AreataGiacomo Caldarola, Antonietta Ferretti, Lorenzo Maria Pinto, et al.
Dermatology Practical & Conceptual|May 29, 2024
Long-Term Effectiveness of Brodalumab for the Treatment of Moderate-To-Severe Psoriasis: A Real-Life Multicenter Study of Up to 3 Years in a Real-Life Italian CohortGiacomo Caldarola, Marco Galluzzo, Nicoletta Bernardini, et al.
Dermatology (Basel, Switzerland)|June 18, 2024
Evaluation of the Impact of Night Shift Work on Disease Severity in Psoriatic Patients: A Case-Control Study with Clinical, Hormonal, and Immunological EvaluationGiacomo Caldarola, Eleonora De Luca, Angelina Barini, et al.
Frontiers in Medicine|January 26, 2024
Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilledGiulia Coscarella, Gennaro Marco Falco, Gerardo Palmisano, et al.
Pageof 4